Healthcare provider profile · identity verified

David Thomas Russell, D.O.

Internal Medicine · PINE GROVE, PA · NPI 1285097592

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	577	165
Amlodipine Besylate	Amlodipine Besylate	463	141
Rosuvastatin Calcium	Rosuvastatin Calcium	409	124
Levothyroxine Sodium	Levothyroxine Sodium	399	108
Pantoprazole Sodium	Pantoprazole Sodium	310	81
Metformin Hcl	Metformin Hcl	308	98
Omeprazole	Omeprazole	252	74
Metoprolol Succinate	Metoprolol Succinate	225	67
Lisinopril	Lisinopril	220	63
Hydrochlorothiazide	Hydrochlorothiazide	200	51
Pravastatin Sodium	Pravastatin Sodium	193	61
Lorazepam	Lorazepam	175	43
Benazepril Hcl	Benazepril Hcl	160	44
Losartan Potassium	Losartan Potassium	157	45
Simvastatin	Simvastatin	157	45
Metoprolol Tartrate	Metoprolol Tartrate	153	37
Allopurinol	Allopurinol	148	42
Gabapentin	Gabapentin	144	31
Escitalopram Oxalate	Escitalopram Oxalate	141	42
Potassium Chloride	Potassium Chloride	127	33
Tramadol Hcl	Tramadol Hcl	120	27
Albuterol Sulfate Hfa	Albuterol Sulfate	118	48
Eliquis	Apixaban	115	29
Ezetimibe	Ezetimibe	115	33
Jardiance	Empagliflozin	106	22
Trazodone Hcl	Trazodone Hcl	106	30
Clopidogrel	Clopidogrel Bisulfate	105	28
Sertraline Hcl	Sertraline Hcl	105	28
Tamsulosin Hcl	Tamsulosin Hcl	101	29
Alprazolam	Alprazolam	94	17
Famotidine	Famotidine	91	22
Alendronate Sodium	Alendronate Sodium	90	32
Duloxetine Hcl	Duloxetine Hcl	90	20
Celecoxib	Celecoxib	89	21
Ozempic	Semaglutide	86	20
Furosemide	Furosemide	82	32
Glimepiride	Glimepiride	81	24
Meloxicam	Meloxicam	76	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	16
Pioglitazone Hcl	Pioglitazone Hcl	71	23
Synthroid	Levothyroxine Sodium	69	18
Ramipril	Ramipril	68	16
Xarelto	Rivaroxaban	67	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Buspirone Hcl	Buspirone Hcl	63	21
Carvedilol	Carvedilol	62	21
Citalopram Hbr	Citalopram Hydrobromide	62	14
Nifedipine Er	Nifedipine	59	15
Fluticasone Propionate	Fluticasone Propionate	58	26
Torsemide	Torsemide	58	16
Metformin Hcl Er	Metformin Hcl	55	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	54	20
Atenolol	Atenolol	54	16
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	51	suppressed
Nebivolol Hcl	Nebivolol Hcl	51	12
Montelukast Sodium	Montelukast Sodium	49	16
Azithromycin	Azithromycin	48	42
Paroxetine Hcl	Paroxetine Hcl	47	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	45	12
Finasteride	Finasteride	44	13
Amoxicillin	Amoxicillin	43	37
Doxycycline Hyclate	Doxycycline Hyclate	43	38
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Clonazepam	Clonazepam	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	suppressed
Irbesartan	Irbesartan	39	14
Prednisone	Prednisone	38	21
Trulicity	Dulaglutide	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	11
Methylprednisolone	Methylprednisolone	35	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Spironolactone	Spironolactone	34	12
Chlorthalidone	Chlorthalidone	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	32	11
Ropinirole Hcl	Ropinirole Hcl	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Valsartan	Valsartan	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	24
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	24	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Dilantin	Phenytoin Sodium Extended	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Icosapent Ethyl	Icosapent Ethyl	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	11
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Naproxen	Naproxen	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Baclofen	Baclofen	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Mupirocin	Mupirocin	17	12
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Donepezil Hcl	Donepezil Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Cephalexin	Cephalexin	12	11
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Nystatin	Nystatin	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error